A robotic system integrated with semiconductor-based ultrasound technology aims to help healthcare providers more easily and confidently perform procedures.

Butterfly Network (Burlington, MA, USA) and Mendaera (San Mateo, CA, USA) have entered into an agreement to commercialize a novel robotic system powered by Butterfly’s Ultrasound-on-Chip technology. Mendaera’s robotic technology is compatible with Butterfly’s proprietary semiconductor-based ultrasound device and connected via Butterfly’s software development kit – Butterfly Garden – creating a system that improves precision and consistency for a wide range of image-guided, needle-based interventions. This new category of robotics will expand access to high-quality interventional treatment, thereby streamlining patient care within a healthcare system facing workforce shortages and burnout. Both companies expect the product’s FDA submission by 2025.

“Mendaera’s robotic system is perfectly suited to leverage Butterfly’s proprietary Ultrasound-on-Chip by benefiting from the wide array of ultrasonic sensing applications that only our chip can offer,” said Darius Shahida, Chief Strategy Officer of Butterfly Network. “We are excited to welcome the Mendaera team as a Powered by Butterfly partner and believe our joint solution will expand Butterfly’s reach and clinical impact into the interventional space.”

“At Mendaera, we envision a world where high-quality intervention is available at every care facility, for each and every patient encounter,” added Josh DeFonzo, Co-Founder and CEO of Mendaera. “It was a clear choice for us to collaborate with Butterfly on our technology roadmap, given their unique and programmable Ultrasound-on-Chip platform and aligned mission to make ultrasonic imaging and intervention ubiquitous.”

http://www.gzjiayumed.com/en/index.asp